PlainRecalls
FDA Drug Moderate Class II Ongoing

Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01

Reported: May 7, 2025 Initiated: April 21, 2025 #D-0389-2025

Product Description

Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01

Reason for Recall

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Details

Recalling Firm
Eugia US LLC
Units Affected
18,867 bags
Distribution
USA nationwide.
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01. Recalled by Eugia US LLC. Units affected: 18,867 bags.
Why was this product recalled?
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 7, 2025. Severity: Moderate. Recall number: D-0389-2025.